News & Updates

Administration rates of antiviral therapy remain low among treatment-eligible patients with chronic hepatitis B virus (CHB) and among CHB patients without human immunodeficiency virus (HIV), reveals a recent study.

Using C-reactive protein (CRP) levels as indicators for early treatment with tocilizumab and dexamethasone can help reduce mortality in hospitalized patients with the coronavirus disease 2019 (COVID-19), a recent study has found.

Patients who have been hospitalized for acute kidney injury (AKI) are at heightened risk of dementia, as reported in a study.

Daily use of aspirin reduces the risk of incident hepatocellular carcinoma (HCC), while the combination of daily aspirin use and statin results in a lower incidence of HCC, which suggests a beneficial interaction, according to a study. In addition, no excess oesophageal variceal haemorrhage (VH) is seen among daily aspirin users compared with nonusers.

Coronavirus disease 2019 (COVID-19) patients treated with remdesivir appear to be at a higher likelihood of having elevated pancreatic enzyme levels, a recent Japan study has found.